MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,870,000 | -31.3% | 147,100 | +47.1% | 0.49% | -10.8% |
| Q1 2015 | $12,907,000 | +179.8% | 100,000 | +116.0% | 0.55% | +172.1% |
| Q4 2014 | $4,613,000 | -59.2% | 46,307 | -59.5% | 0.20% | -60.4% |
| Q3 2014 | $11,310,000 | -51.9% | 114,400 | -62.5% | 0.51% | -43.6% |
| Q2 2014 | $23,501,000 | -29.8% | 304,900 | -41.4% | 0.90% | -47.2% |
| Q1 2014 | $33,465,000 | -44.0% | 519,900 | -44.5% | 1.71% | -37.6% |
| Q4 2013 | $59,726,000 | +36.1% | 936,100 | +27.9% | 2.74% | +27.0% |
| Q3 2013 | $43,868,000 | +19.3% | 732,000 | -2.0% | 2.16% | -0.9% |
| Q2 2013 | $36,776,000 | – | 747,194 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |